作者:Miriam Frieden、Matthieu Giraud、Colin B. Reese、Quanlai Song
DOI:10.1039/a803878c
日期:——
4-(Benzylsulfanyl)pyrimidin-2(1H)-one 6a is prepared from 1-benzoyluracil 10a in three steps and in satisfactory overall yield. Reproducible conditions are found for the cycloaddition reaction between allyl benzyl ether and dichloroketene, leading to the cyclobutanone derivative 17 in good yield. trans-3-(Benzyloxymethyl)cyclobutan-1-ol 15 reacts under standard Mitsunobu conditions with the pyrimidine derivative 6a on O-2 to give compound 20, which is converted into 2-[cis-3-(hydroxymethyl)-cyclobutoxy]pyrimidin-4(3H)-one 24 in good overall yield. Under the same Mitsunobu conditions, 3-benzoyluracil 11a and 3-benzoylthymine 11b react with the trans-alcohol 15 on N-1 to give their 1-[cis-3-(benzyloxymethyl)cyclobutyl] derivatives 27a and 27b, respectively. The latter compounds 27a and 27b are converted into 1-[cis-3-(hydroxymethyl)cyclobutyl]uracil 13a and 1-[cis-3-(hydroxymethyl)cyclobutyl]thymine 13b in satisfactory overall yields. The uracil derivative 13a is converted into 1-[cis-3-(hydroxymethyl)cyclobutyl]cytosine 14 in good yield.
4-(苄巯基)嘧啶-2(1H)-酮6a通过三步反应从1-苯甲酰脲10a制备,总产率令人满意。找到了烯丙基苄基醚与二氯碳烯环加成反应的可重复条件,生成的环丁酮衍生物17产率良好。反式-3-(苄氧甲基)环丁醇15在标准的三乙胺条件下与嘧啶衍生物6a的O-2位反应,得到化合物20,再转化为2-[顺式-3-(羟甲基)环丁氧基]嘧啶-4(3H)-酮24,总产率良好。在相同的三乙胺条件下,3-苯甲酰脲11a和3-苯甲酰胸腺嘧啶11b与反式醇15的N-1位反应,分别生成它们的1-[顺式-3-(苄氧甲基)环丁基]衍生物27a和27b。后两者化合物27a和27b分别转化为1-[顺式-3-(羟甲基)环丁基]脲13a和1-[顺式-3-(羟甲基)环丁基]胸腺嘧啶13b,总产率令人满意。脲衍生物13a被转化为1-[顺式-3-(羟甲基)环丁基]胞嘧啶14,产率良好。